The FDA had uncertainty about the degree of clinical benefit for Novocure’s treatment of brain metastases, the company said.

The agency is inviting public comment on a new discussion paper as it prepares to shape policy covering robotic medical ...

The medical device company’s stock dropped when the market opened Wednesday after it slashed sales and earnings forecasts ...

Edwards’ TAVR device in moderate aortic stenosis drew applause from meeting attendees, while Medtronic’s renal denervation ...

CEO Ivan Tornos did not attribute the company’s performance in knees to a broader market slowdown, as competitor Stryker did ...

The CEO change was unexpected and prompted a stock selloff Friday, analysts said, but the new chief executive is prepared for ...

The first-of-its-kind transcatheter device treats paravalvular leak after valve replacement surgery, to spare the patient ...

The company notified customers this month that it will discontinue Medline brand beds and associated products and exit the ...

M&A rose, but company valuations declined in the first half of 2026 compared with the year-ago period, according to EY’s ...

CEO Kevin Lobo said the slowdown in hip and knee procedures is tied to broader economic concerns. The outgoing CEO also ...

Stryker said Monday it has closed its takeover of ZuriMED, adding a device for treating rotator cuff tears to its portfolio.

Labcorp said Friday it has struck a deal to buy Millennium Health, an accredited specialty laboratory. Financial terms were not disclosed. Millennium offers testing services to help clinicians monitor ...